Skip to main content

Nevro Corp

NVRODelisted Apr 3, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001444380

Nevro Corp was delisted on Apr 3, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 127 institutions reported holding it in 13F filings for Q1 2025, worth $197.5M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
127
Q1 2025, −1 vs. previous quarter
13F value
$197.5M
Reported value at the end of Q1 2025
Superinvestors holding
0
At the end of Q1 2025

From SEC filings, in USD.

Revenue, FY2024
$408.5M
−3.9% year over year
Net income, FY2024
-$113.4M
No comparable prior period
Free cash flow, FY2024
-$29.2M
No comparable prior period
Revenue, Q4 FY2024
$105.5M
−9.1% year over year

Revenue flow, FY2024

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2024: $113.4M (27.8% of revenue).

Superinvestors holding NVRO, Q1 2025

Go to the superinvestors tab

No superinvestor reported holding NVRO at the end of Q1 2025.

Latest insider trades

See all insider trades

Open-market purchases and sales by Nevro Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 9, 2023 (view filing)Jun 72 daysMcCormick ShawnDirectorPPurchase+7.50K$22.88+$171.6K+38.7%26.9K after
May 10, 2022 (view filing)May 91 dayRashid KashifGeneral CounselPPurchase+2.25K$44.50+$100.1K+4.4%53.5K after
Mar 14, 2022 (view filing)Mar 113 daysRashid KashifGeneral CounselPPurchase+1.50K$64.04+$96.1K+3.0%51.3K after
Mar 8, 2022 (view filing)Mar 8Same dayGrossman D KeithChairman, President & CEOPPurchase+3.20K$63.59+$203.5K+1.9%169.3K after
Dec 16, 2021 (view filing)Dec 142 daysOboyle Kevin CDirectorPPurchase+2.40K$83.78+$201.1K+22.0%13.3K after2 lots
Nov 22, 2021 (view filing)Nov 22Same dayWeatherman Elizabeth HDirectorPPurchase+20.0K$85.33+$1.71M+109.1%38.3K after2 lots
Nov 15, 2021 (view filing)Nov 114 daysRashid KashifGeneral CounselPPurchase+2.00K$101.05+$202.1K+6.1%34.5K after
Aug 17, 2021 (view filing)Aug 134 daysGrossman D KeithChairman, President & CEOPPurchase+7.00K$105.07+$735.5K+5.9%125.8K after

Top 10 13F holders, Q1 2025

See all 127 holders

The largest institutional positions in Nevro Corp at the end of Q1 2025; share changes are against Q4 2024.

Institutions holding NVRO in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Beryl Capital Management LLC3,761,191$22.0M8.21%+3,761,191New
BlackRock, Inc.2,930,783$17.1M0.00%−117,703−3.9%Reduced
Goldman Sachs Group Inc2,072,813$12.1M0.00%+1,617,676+355.4%Added
Vanguard Group Inc2,070,027$12.1M0.00%+7,834+0.4%Added
Oddo BHF Asset Management SAS1,850,000$10.8M0.44%+1,850,000New
Meteora Capital, LLC1,723,715$10.1M3.56%+1,723,715New
Gardner Lewis Asset Management L P1,630,291$9.52M2.29%+1,630,291New
Gabelli Funds LLC1,322,950$7.73M0.06%+1,322,950New
D. E. Shaw & Co., Inc.1,251,830$7.31M0.01%−551,702−30.6%Reduced
Renaissance Technologies LLC1,209,409$7.06M0.01%+909,100+302.7%Added

Holders of 5% or more of NVRO

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nevro Corp.

Largest holders of NVRO from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G/A9.97%3.74M shares–Feb 14, 20243 filingsFeb 14, 2025SEC